Iga Swiatek, the No. 2 ranked ladies’s tennis participant on this planet, has accepted a one-month suspension for violating the Tennis Anti-Doping Program, the International Tennis Integrity Agency announced on Thursday. Swiatek examined optimistic for trimetazidine (TMZ), which is a banned substance.
Again in August, Swiatek examined optimistic in an out-of-competition pattern. Following an investigation, the ITIA decided that the optimistic pattern was the results of Swiatek taking over-the-counter melatonin for sleeping points.
As a result of the optimistic pattern was deemed to be unintentional, the ITIA categorised Swiatek’s stage of fault as “No vital fault or negligence.”
In a video posted to Instagram, Swiatek mentioned she was nervous about how the optimistic take a look at would have an effect on her profession.
“The entire thing will certainly stick with me for the remainder of my life. It took lots to return to coaching after the state of affairs almost broke my coronary heart, so there have been many tears and many sleepless nights,” Swiatek mentioned. “The worst a part of it was the uncertainty. I did not know what was going to occur with my profession, how issues would finish or if I’d be allowed to play tennis in any respect.”
Swiatek, a five-time Grand Slam champion, is coming off a 12 months by which she gained the French Open and earned a bronze medal on the 2024 Paris Olympics.
This is not the one doping scandal that has impacted tennis in current months. Prime-ranked males’s tennis participant Jannik Sinner examined optimistic twice for a banned anabolic steroid again in March. Nevertheless, Sinner’s optimistic take a look at was additionally decided to be unintentional, and he avoided suspension entirely.
